Delivery Order SPE2DB24D2011-SPE2DB25FBRLF
- Not listed
- The Defense Logistics Agency awarded a $2,847.65 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This is a firm fixed price contract with no set-aside designation, competitively awarded under an open procurement process. The contract requires delivery by July 30, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication...
- The Defense Logistics Agency awarded a $9,283.93 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 25, 2025, with completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Carvedilol is a beta-blocker used to treat heart failure and hypertension, representing routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $22,717.96 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count units). This contract employs firm fixed-price terms with an ultimate completion date of August 20, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,434.11 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count packages). This contract award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a cardiovascular...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carvedilol ER 10 mg capsules in quantities of 30 units. This contract is a firm fixed-price delivery order with a ceiling value of $8,619.00 and an ultimate completion date of August 8, 2025. The award was made through open competition with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,054.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packaging). The contract is valued at $9,434.27 under a firm fixed-price arrangement with an ultimate completion date of August 15, 2025. This delivery order was awarded competitively with no set-aside designation and represents performance at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,175.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 31, 2025, with completion expected by August 1, 2025. This is an unset-aside, competitively awarded contract with performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on July 31, 2025, with a firm fixed price ceiling value of $9,931.33 and an ultimate completion date of August 1, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999.99 billion pharmaceutical prime vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRLFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,927.27 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, non-set-aside contract was awarded competitively and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and veteran healthcare systems for cardiovascular management, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply needs across the federal healthcare enterprise. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's substantial federal contract portfolio and demonstrated capability to meet competitive procurement requirements have established it as a critical vendor for federal medical supply chains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 7/31/25 |